title: Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors.
abstract: The introduction of nucleot(s)ide analogues (NAs) for oral antiviral therapy has dramatically improved the clinical outcome of patients with chronic hepatitis B. NAs appear to be safe and induce potent suppression of viral replication. However, they are associated with a low rate of HBsAg seroclearance, the gold standard of successful treatment, and also with a relatively high rate of virological relapse after discontinuation. As a result, long-term treatment is needed. The optimal duration of NA treatment currently remains unclear, nevertheless in some patients NA treatment can be stopped with a relatively low probability of relapse. Whether NAs are able to induce a sustained off-treatment response is an important area for research. This article reviews the relapse rate after cessation of treatment with NAs in chronic hepatitis B patients with the goal of identifying possible predictive factors of relapse.
authors.affiliation: Department of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, United Kingdom (Hariklia Kranidioti, Salim I. Khakoo).
authors.forename: Hariklia
authors.initials: H
authors.lastname: Kranidioti
authors.affiliation: 2 Academic Department of Internal Medicine, Hippokration General Hospital, University of Athens, Greece (Spilios Manolakopoulos).
authors.forename: Spilios
authors.initials: S
authors.lastname: Manolakopoulos
authors.affiliation: Department of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, United Kingdom (Hariklia Kranidioti, Salim I. Khakoo).
authors.forename: Salim I
authors.initials: SI
authors.lastname: Khakoo
keywords: Chronic hepatitis B; nucleot(s)ides analogues; stopping therapy
references.citation: Gut. 2015 Jan;64(1):139-47
references.pmid: 24555998
references.citation: Hepatology. 2010 Sep;52(3):886-93
references.pmid: 20683932
references.citation: Hepatology. 2003 Apr;37(4):748-55
references.pmid: 12668966
references.citation: Gastroenterology. 2012 Sep;143(3):629-36.e1
references.pmid: 22659218
references.citation: J Gastroenterol Hepatol. 2005 Dec;20(12):1838-42
references.pmid: 16336441
references.citation: Antivir Ther. 2010;15(2):133-43
references.pmid: 20386068
references.citation: N Engl J Med. 1998 Jul 9;339(2):61-8
references.pmid: 9654535
references.citation: J Gastroenterol Hepatol. 2011 Mar;26(3):456-60
references.pmid: 21332542
references.citation: J Hepatol. 2003 Oct;39(4):614-9
references.pmid: 12971973
references.citation: Hepatology. 2004 Jun;39(6):1694-701
references.pmid: 15185311
references.citation: Semin Liver Dis. 2004;24 Suppl 1:17-21
references.pmid: 15192797
references.citation: Gut. 2000 Apr;46(4):562-8
references.pmid: 10716688
references.citation: Gastroenterology. 2007 Feb;132(2):543-50
references.pmid: 17258721
references.citation: Hepatology. 2000 Oct;32(4 Pt 1):803-6
references.pmid: 11003626
references.citation: PLoS One. 2013 Jul 03;8(7):e68568
references.pmid: 23844222
references.citation: Gut. 2015 Apr;64(4):667-72
references.pmid: 24833635
references.citation: Hepatology. 2010 Feb;51(2):415-21
references.pmid: 19902424
references.citation: Gut. 2005 Nov;54(11):1604-9
references.pmid: 15923670
references.citation: Lancet. 2013 Feb 9;381(9865):468-75
references.pmid: 23234725
references.citation: J Hepatol. 2010 Aug;53(2):348-56
references.pmid: 20483498
references.citation: Gut. 2003 Mar;52(3):420-4
references.pmid: 12584227
references.citation: Hepatology. 2003 Nov;38(5):1267-73
references.pmid: 14578866
references.citation: Hepatology. 2013 Sep;58(3):923-31
references.pmid: 23468172
references.citation: J Korean Med Sci. 2010 Jun;25(6):882-7
references.pmid: 20514309
references.citation: Gut. 2014 Aug;63(8):1325-32
references.pmid: 24162593
references.citation: J Viral Hepat. 2004 Sep;11(5):432-8
references.pmid: 15357648
references.citation: N Engl J Med. 1999 Oct 21;341(17):1256-63
references.pmid: 10528035
references.citation: Hepatology. 2013 Dec;58(6):1885-7
references.pmid: 24037945
references.citation: Hepatology. 2000 Sep;32(3):635-9
references.pmid: 10960461
references.citation: Korean J Hepatol. 2011 Dec;17(4):261-7
references.pmid: 22310790
references.citation: Gut. 2004 Sep;53(9):1363-5
references.pmid: 15306601
references.citation: Antivir Ther. 2013;18(8):979-86
references.pmid: 23744529
references.citation: Hepatology. 2009 Sep;50(3):661-2
references.pmid: 19714720
references.citation: Hepatology. 2013 Dec;58(6):1888-96
references.pmid: 23744454
references.citation: J Int Med Res. 2013 Oct;41(5):1732-9
references.pmid: 23908397
references.citation: Antivir Ther. 2011;16(8):1249-57
references.pmid: 22155906
references.citation: Antivir Ther. 2006;11(7):947-52
references.pmid: 17302259
references.citation: Scand J Gastroenterol. 2013 Jun;48(6):745-51
references.pmid: 23586360
references.citation: Gut. 2011 Aug;60(8):1109-16
references.pmid: 21270118
references.citation: BMC Infect Dis. 2013 Oct 03;13:458
references.pmid: 24090287
references.citation: Clin Mol Hepatol. 2013 Sep;19(3):300-4
references.pmid: 24133668
references.citation: Arch Virol. 2012 Feb;157(2):285-90
references.pmid: 22080196
references.citation: J Viral Hepat. 2010 Jan;17(1):16-22
references.pmid: 19622117
references.citation: Gastroenterology. 2008 Oct;135(4):1192-9
references.pmid: 18722377
references.citation: Hepatology. 1991 Apr;13(4):627-31
references.pmid: 2010157
references.citation: J Hepatol. 2009 Jun;50(6):1084-92
references.pmid: 19376603
references.citation: J Clin Gastroenterol. 2012 Nov-Dec;46(10):865-70
references.pmid: 22941429
references.citation: Am J Gastroenterol. 2004 Jan;99(1):57-63
references.pmid: 14687142
references.citation: Hepatology. 2010 Feb;51(2):422-30
references.pmid: 20049753
references.citation: J Hepatol. 2012 Jul;57(1):167-85
references.pmid: 22436845
references.citation: Gastroenterology. 2010 Aug;139(2):491-8
references.pmid: 20381492
references.citation: Virol J. 2012 Oct 18;9:239
references.pmid: 23078793
references.citation: J Infect Dis. 2011 Aug 1;204(3):415-8
references.pmid: 21742840
references.citation: Aliment Pharmacol Ther. 2011 Aug;34(3):344-52
references.pmid: 21671967
references.citation: Gastroenterology. 2011 Jan;140(1):132-43
references.pmid: 20955704
references.citation: J Hepatol. 2013 Apr;58(4):676-83
references.pmid: 23219442
references.citation: J Viral Hepat. 2010 Apr;17(4):298-304
references.pmid: 19758278
references.citation: Hepatol Int. 2008 Sep;2(3):263-83
references.pmid: 19669255
references.citation: Ann Oncol. 2011 May;22(5):1170-80
references.pmid: 21115603
references.citation: J Gastroenterol Hepatol. 2003 Mar;18(3):246-52
references.pmid: 12603523
references.citation: BMC Infect Dis. 2014 Aug 13;14:439
references.pmid: 25125320
references.citation: Hepatology. 2007 May;45(5):1187-92
references.pmid: 17465003
references.citation: J Hepatol. 2014 Sep;61(3):515-22
references.pmid: 24798617
references.citation: J Hepatol. 2009 Feb;50(2):289-95
references.pmid: 19070393
references.citation: Gastroenterology. 2008 Aug;135(2):459-67
references.pmid: 18585385
references.citation: Clin Gastroenterol Hepatol. 2006 Sep;4(9):1076-81
references.pmid: 16861051
references.citation: Gastroenterology. 2012 Oct;143(4):963-73.e9
references.pmid: 22796241
references.citation: Am J Gastroenterol. 2009 Aug;104(8):1940-6; quiz 1947
references.pmid: 19455108
references.citation: Intervirology. 2005;48(6):341-9
references.pmid: 16024938